
Elan Diamond MD
Myeloproliferative Disorder Hematology-Oncology
Physician
Join to view full profile
1515 Broad StSte B120Bloomfield, NJ 07003
Phone+1 973-873-7000
Fax+1 973-767-1321
Dr. Diamond is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2012 - 2015
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2011
Weill Cornell MedicineClass of 2008
Certifications & Licensure
NJ State Medical License 2015 - 2027
NY State Medical License 2011 - 2016
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
Publications & Presentations
PubMed
- 41 citationsCytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapyEli L. Diamond, Ana M. Molina, Marisa Carbonaro, Naveed Akhtar, Paraskevi Giannakakou
Critical Reviews in Oncology/hematology. 2015-12-01 - 2 citationsThe Evolving Role of Cytotoxic Chemotherapy in the Management of Patients with Metastatic Prostate CancerElan Diamond, María del Carmen Garcias, Beerinder S. Karir, Scott T. Tagawa
Current Treatment Options in Oncology. 2015-03-12 - 10 citationsImmunologics and Chemotherapeutics for Renal Cell CarcinomaElan Diamond, Jamie Riches, Bishoy Faltas, Scott T. Tagawa, David M. Nanus
Seminars in Interventional Radiology. 2014-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









